Literature DB >> 33476792

Air particulate matter pollution and circulating surfactant protein: A systemic review and meta-analysis.

Zhenjie Wang1, Mengmeng Xu1, Yanhua Wang1, Ting Wang1, Nan Wu1, Wenjing Zheng2, Huawei Duan3.   

Abstract

OBJECTIVE: Air particulate matter (PM) pollution is associated with the alterations in circulating pulmonary damage proteins. But there are not consistent results among the epidemiological studies. The aim of this study is to investigate the alteration of surfactant protein (SP) from PM exposure.
METHODS: We conducted a comprehensive meta-analysis by searching the databases of PubMed, Medline, EMBASE, Web of Science and CNKI before October 2020 which reported PM pollutants and surfactant protein in the population. The sources of heterogeneity were assessed by subgroup (smoking, particulate matter with different aerodynamic diameter, exposure duration) analysis. We also used the publication bias tests for the comprehensive assessment.
RESULTS: This meta-analysis consisted of 10 studies with 1985 subjects. The results showed that the combined standardized mean difference (SMD) value was 0.05, 95% confidence interval (CI) was -0.07 to 0.17 for serum SP-A and -0.81 (95% CI: -1.41 to -0.21) for circulating SP-D. Among smokers, the combined SMD value of SP-A were 0.29 (95% CI: 0.05 to 0.52). We did not find the correlation between publication year of SP-A and SP-D and study heterogeneity.
CONCLUSIONS: Circulating SP-D was significantly decreased by air particulate matter. Serum SP-A was significantly increased by PM exposure among smokers. Circulating surfactant protein may be considered as a biomarker for respiratory injury caused by air particulate matter.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Air pollution; Particulate matter; Respiratory damage; Surfactant protein

Mesh:

Substances:

Year:  2021        PMID: 33476792     DOI: 10.1016/j.chemosphere.2021.129564

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  1 in total

1.  Ambroxol Treatment Suppresses the Proliferation of Chlamydia pneumoniae in Murine Lungs.

Authors:  Dávid Kókai; Dóra Paróczai; Dezső Peter Virok; Valéria Endrész; Renáta Gáspár; Tamás Csont; Renáta Bozó; Katalin Burián
Journal:  Microorganisms       Date:  2021-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.